Health Catalyst Announces Q2 2025 Earnings Release and Conference Call on August 7, 2025

Friday, Jul 18, 2025 4:52 pm ET1min read

Health Catalyst will announce Q2 2025 earnings on Aug 7, 2025, after market close. A conference call will follow at 5:00 PM ET. The call will be accessible via phone and a live webcast, with a replay available for 90 days. The company provides data and analytics technology for the healthcare sector, with its cloud-based ecosystem trusted by over 1,000 organizations worldwide.

Health Catalyst (NASDAQ: HCAT), a leading provider of data and analytics technology for the healthcare sector, has scheduled the release of its second quarter 2025 operating results for Thursday, August 7, 2025, after market close. The company will host a conference call at 5:00 PM ET on the same day to discuss the results [1].

Investors and stakeholders can access the conference call by dialing 800-343-5172 for U.S. participants or 203-518-9856 for international participants, using the conference ID "HCATQ225". A live audio webcast will be available online at https://ir.healthcatalyst.com/ [1].

Health Catalyst's cloud-based technology ecosystem, Health Catalyst Ignite™, and AI-enabled data and analytics solutions are trusted by over 1,000 organizations worldwide. The company's mission is to deliver significant, data-driven improvements in the healthcare sector, with a proven track record of delivering billions in measurable results [1].

The company's investor relations contact is Jack Knight, Vice President of Investor Relations, who can be reached at +1 (855) 309-6800 or via email at ir@healthcatalyst.com [1].

References:
[1] https://www.stocktitan.net/news/HCAT/health-catalyst-to-announce-second-quarter-2025-operating-results-u8rl80bl10xn.html
[2] https://www.nasdaq.com/articles/health-catalyst-inc-announce-q2-2025-operating-results-and-host-conference-call-august-7

Health Catalyst Announces Q2 2025 Earnings Release and Conference Call on August 7, 2025

Comments



Add a public comment...
No comments

No comments yet